United Therapeutics Director Nilda Mesa Exercises Options and Sells 228 Shares
UNITED THERAPEUTICS Corp
Subscribe to track UTHR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insider Transaction Alert: UNITED THERAPEUTICS Corp ($UTHR) • Insider: Mesa Nilda (Director) • Transaction: Option Exercise & Sale • Shares Sold: 228 shares @ ~$505.87 avg ($115.34K total value) • Shares Acquired via Exercise: 130 shares @ $110.86 • Ending Direct Ownership: 5,580 shares • Filing Date: 2026-09-15
Comprehensive Analysis
Executive Summary
On September 15, 2026, United Therapeutics Corp ($UTHR) filed a Form 4 disclosing transactions by Director Nilda Mesa on September 14, 2026. The insider exercised stock options for 130 shares at $110.86 and executed open-market sales totaling 228 shares at an average price of approximately $505.87 per share, generating aggregate gross proceeds of approximately $115,338.
Transaction Breakdown
- Option Exercise (Code M): 130 shares exercised at $110.86 per share.
- Open Market Sale (Code S): 130 shares sold at a weighted average price of $505.7868 (range: $505.76 to $505.985).
- Open Market Sale (Code S): 98 shares sold at $505.975 per share.
- Post-Transaction Holdings: Mesa retains direct ownership of 5,580 shares of common stock and 6,430 remaining stock options.
Market & Governance Context
Given the relatively small transaction size (~$115K) and routine exercise of expiring or vested director stock options, this activity carries Low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.